Evidence map›Paper›PMID 35451026›Full record

ArticleHuman molecular genetics2022

A Polynesian-specific copy number variant encompassing the MICA gene associates with gout.

Ke Wang, Murray Cadzow, Matt Bixley, Megan P Leask, Marilyn E Merriman, Qiangzhen Yang, Zhiqiang Li, Riku Takei, Amanda Phipps-Green, Tanya J Major and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Hyperuricaemia and gout in the Pacific.Nature reviews. Rheumatology · 2025
    Review
  4. Review
  5. Review
  6. A PolynesianHGG advances · 2023
    Article
  7. High population frequencies ofFrontiers in immunology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 3 countries.

Ke WangBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, People's Republic of China.
Murray CadzowDepartment of Biochemistry, University of Otago, Dunedin 9054, New Zealand.
Matt BixleyDepartment of Biochemistry, University of Otago, Dunedin 9054, New Zealand.
Megan P LeaskDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Marilyn E MerrimanDepartment of Biochemistry, University of Otago, Dunedin 9054, New Zealand.
Qiangzhen YangBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, People's Republic of China.
Zhiqiang LiBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, People's Republic of China.
Riku TakeiDepartment of Biochemistry, University of Otago, Dunedin 9054, New Zealand.
Amanda Phipps-GreenDepartment of Biochemistry, University of Otago, Dunedin 9054, New Zealand.
Tanya J MajorDepartment of Biochemistry, University of Otago, Dunedin 9054, New Zealand.
Ruth ToplessDepartment of Biochemistry, University of Otago, Dunedin 9054, New Zealand.
Nicola DalbethDepartment of Medicine, University of Auckland, Auckland 1023, New Zealand.
Frances KingNgati Porou Hauora Charitable Trust, Te Puia Springs, New Zealand.
Rinki MurphyDepartment of Medicine, University of Auckland, Auckland 1023, New Zealand.
Lisa K StampDepartment of Medicine, University of Otago, Christchurch 8013, New Zealand.
Janak de ZoysaDepartment of Medicine, University of Auckland, Auckland 1023, New Zealand.
Zhuo WangBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, People's Republic of China.
Yongyong ShiBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, People's Republic of China.
Tony R MerrimanDepartment of Biochemistry, University of Otago, Dunedin 9054, New Zealand.ORCID 0000-0003-0844-8726
University of Otago · NZShanghai Jiao Tong University · CNUniversity of Alabama at Birmingham · USUniversity of Auckland · NZQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gout is of particularly high prevalence in the Māori and Pacific (Polynesian) populations of Aotearoa New Zealand (NZ). Here, we investigated the contribution of common population-specific copy number variation (CNV) to gout in the Aotearoa NZ Polynesian population. Microarray-generated genome-wide genotype data from Aotearoa NZ Polynesian individuals with (n = 1196) and without (n = 1249) gout were analyzed. Comparator population groups were 552 individuals of European ancestry and 1962 of Han Chinese ancestry. Levels of circulating major histocompatibility complex (MHC) class I polypeptide-related sequence A (MICA) were measured by enzyme-linked immunosorbent assay. Fifty-four CNV regions (CNVRs) appearing in at least 10 individuals were detected, of which seven common (>2%) CNVRs were specific to or amplified in Polynesian people. A burden test of these seven revealed associations of insertion/deletion with gout (odds ratio (OR) 95% confidence interval [CI] = 1.80 [1.01; 3.22], P = 0.046). Individually testing of the seven CNVRs for association with gout revealed nominal association of CNVR1 with gout in Western Polynesian (Chr6: 31.36-31.45 Mb, OR = 1.72 [1.03; 2.92], P = 0.04), CNVR6 in the meta-analyzed Polynesian sample sets (Chr1: 196.75-196.92 Mb, OR = 1.86 [1.16; 3.00], P = 0.01) and CNVR9 in Western Polynesian (Chr1: 189.35-189.54 Mb, OR = 2.75 [1.15; 7.13], P = 0.03). Analysis of European gout genetic association data demonstrated a signal of association at the CNVR1 locus that was an expression quantitative trait locus for MICA. The most common CNVR (CNVR1) includes deletion of the MICA gene, encoding an immunomodulatory protein. Expression of MICA was reduced in the serum of individuals with the deletion. In summary, we provide evidence for the association of CNVR1 containing MICA with gout in Polynesian people, implicating class I MHC-mediated antigen presentation in gout.

Indexed as

DNA Copy Number VariationsGoutHistocompatibility Antigens Class IPacific Island PeopleGenotypeHLA AntigensHumansNew ZealandHistocompatibility Antigens Class IHLA AntigensMHC class I-related chain A

Identifiers

PMID35451026
PMCPMC9616569
OpenAlexW4224291403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.